CD8A and neoplasm: The CD45.1+ CD8+ T cells and CD45.2+ CD8+ T cells were then co-transferred into the same Rag2−/− mice bearing PD-L1-KO B16F10 tumor at 1:1 ratio, so that they function in the same tumor microenvironment.